Breakthrough urine test could soon be used to detect one of the most common forms of cancer
Stay up to date with notifications from The Independent
Notifications can be managed in browser preferences.
New test could detect one of the most common forms of cancer
- Scientists have identified a set of markers in urine that could lead to a more accurate and less invasive test for prostate cancer.
- Current PSA blood tests often result in false positives and unnecessary biopsies.
- The new markers, including molecules like SPON2, AMACR, and TMEFF2, are more precise than PSA in detecting prostate cancer presence and severity, according to a new study.
- Researchers used AI and gene activity analysis to identify these markers from tumour samples and validated the findings with patient samples.
- This urine test could enable earlier diagnosis, better prognoses, and reduce unnecessary biopsies, pending further validation in larger populations.